| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 30 |
| 1 | BRENTUXIMAB VEDOTIN | 27 |
| 2 | VALACYCLOVIR | 27 |
| 3 | VALACYCLOVIR HYDROCHLORIDE | 27 |
| 4 | URSODIOL | 26 |
| 5 | URSOSIOL | 25 |
| 6 | METOPROLOL TARTRATE | 24 |
| 7 | METOPROLOL | 23 |
| 8 | ASPIRIN | 22 |
| 9 | ASPIRIN 325 MG | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SABAL SERRULATA, CHIMAPHILA UMBELLATA, PROSTATE (SUIS), ZINCUM METALLICUM, PULSATILLA (PRATENSIS) | 1 | 0.0769 |
| 1 | ARGININE HYDROCHLORIDE | 1 | 0.0097 |
| 2 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 3 | CETRORELIX ACETATE | 2 | 0.0032 |
| 4 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 3 | 0.0027 |
| 5 | BRENTUXIMAB VEDOTIN | 27 | 0.0026 |
| 6 | MILK THISTLE | 4 | 0.0018 |
| 7 | OMAVELOXOLONE | 3 | 0.0017 |
| 8 | CLOMIPHENE CITRATE | 2 | 0.0013 |
| 9 | DORAVIRINE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 59 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 34 |
| 3 | Proton Pump Inhibitor [EPC] | 34 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 32 |
| 5 | CD30-directed Immunoconjugate [EPC] | 27 |
| 6 | Platinum-based Drug [EPC] | 27 |
| 7 | Atypical Antipsychotic [EPC] | 26 |
| 8 | Bile Acid [EPC] | 26 |
| 9 | Alkylating Drug [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 27 | 0.0026 |
| 1 | Bile Acid [EPC] | 26 | 0.0011 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 14 | 0.0011 |
| 4 | Leptin Analog [EPC] | 1 | 0.0008 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 6 | Polyene Antifungal [EPC] | 14 | 0.0003 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 8 | 0.0003 |